Evidence
Aliment Pharmacol Ther. 2024 May;59(10):1294-1295. doi: 10.1111/apt.17992.
NO ABSTRACT
PMID:38652769 | DOI:10.1111/apt.17992
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
- #ADHD
- Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium
- A Comparison of Effectiveness of Attention Process Training (APT) with Parenting Management Training (PMT) in Reducing Symptoms of Attention Deficit Hyperactivity Disorder
- Modeling resilience to sleep disruption to study resistance to Alzheimer's disease
- High prevalence of treatment with ADHD medicines indicates overdiagnosis of ADHD in Iceland
- The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019
- Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Reduced risk tolerance and cortical excitability following COVID-19 infection
- Reduced risk tolerance and cortical excitability following COVID-19 infection
- Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health
- Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis
- Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
- Natural product pharmacology: the British Journal of Pharmacology perspective
- Editorial: Reciprocity between sleep and mood in early childhood - an under-explored neural marker of depression risk
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center
- Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Editorial: The Cass Review - implications and reassurance for practitioners
- Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease
- The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes
- The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes
- The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes
- Mentalizing individuals, families and systems: Towards a translational socioecological approach
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study
- Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study
- Comment on Lawson et al
- Evidence and policy is certainly more complex than it seems
- Evidence and policy is certainly more complex than it seems
- Swept up in the tsunami: Pediatric and adolescent steatotic (fatty) liver disease
- Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease
- Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease
- Two new cases of poppy seed tea dependence: using new formulations for an old condition
- Depression and delirium: association, prediction, causation, and care
- Assisted bathing of older adults with dementia
- Progress in perinatal mental health research
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Correction to "Peer contagion dynamics in the friendships of children with ADHD"
- Association between race and ethnicity and delirium incidence in acute care
- Should we combine antipsychotics in patients with bipolar disorder?
- Need for further exploring at the intersection of ADHD medications and bipolar disorder
- Correction to "Social setting interacts with hyper dopamine to boost the stimulant effect of ethanol"
- Telemedicine experience among family caregivers of persons with dementia
- A retrospective cohort study of hospital discharge instructions following delirium episodes
- Cognitive outcomes of children and adults with sickle cell anaemia: A contemporary cohort
- Autism screening is critical for the most vulnerable children
- Commentary on Zendle and Newall: The need for direct evaluation of the UK's gambling affordability checks policy
- Children with elevated wheat IgG4 antibody titer in autism spectrum disorder: Clinical presentation and findings associated with gut microbiota
- Children with elevated wheat IgG4 antibody titer in autism spectrum disorder: Clinical presentation and findings associated with gut microbiota
- Introduction to Progress and Puzzles of Cognitive Science: Introduction to a Wiley Virtual Issue
- Letter to the Editor concerning "Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression"
- Menopause and bipolar disorder: Bridging research gaps and exploring postmenopause
- Enhancing remote nursing education in Taiwan: Lessons from the COVID-19 pandemic and future directions
- Experiences of children and adolescents with attention-deficit/hyperactivity disorder taking methylphenidate
- Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation
- George Robert Siggins: Researcher, musician, surfer, mentor, and friend
Evidence Blueprint
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
- Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
- Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
- Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
- Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population
- #ADHD
- Psychedelics in treatment of postraumatic stress disorder
- Review article: Hepatic steatosis and its associations with acute and chronic liver diseases
- Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies
- Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis
- Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity
- Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium
- Meta-analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non-alcoholic steatohepatitis and non-alcoholic steatohepatitis-related fibrosis
- Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study
- Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma
- Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis
- MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease
- First in human randomised trial of J2H-1702: A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment
- MDMA-assisted therapy for PTSD
- A Comparison of Effectiveness of Attention Process Training (APT) with Parenting Management Training (PMT) in Reducing Symptoms of Attention Deficit Hyperactivity Disorder
- Modeling resilience to sleep disruption to study resistance to Alzheimer's disease
- High prevalence of treatment with ADHD medicines indicates overdiagnosis of ADHD in Iceland
- The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019
- Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity
- Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population-based cohort study
- Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment
- Potential Mechanisms Involving in the Pathogenesis of MASLD and Targets for Pharmacotherapy. Advancements in Metabolic Associated Steatotic Liver Disease (MASLD) Research: Diagnostics, Small Molecule Developments and Future Directions
- Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment
- Letter regarding 'Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes'
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Z-Spectral MRI Quantifies the Mass and Metabolic Activity of Adipose Tissues With Fat-Water-Fraction and Amide-Proton-Transfer Contrasts
- Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia
- The promise of N-acetylcysteine in the treatment of obsessive-compulsive disorder
- Reduced risk tolerance and cortical excitability following COVID-19 infection
- Reduced risk tolerance and cortical excitability following COVID-19 infection
- Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification
- A novel dual near-infrared fluorescent probe for bioimaging and visualization of viscosity in acute alcoholic liver injury
- Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus
- Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
- Editorial: Prevention is the best cure - or is it? A cautionary tale
- Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross-sectional study
- Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health
- Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis
- Correction to "Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis"
- Commentary on Booth et al.: Measuring the health burden of homelessness
- Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype
- Liver disease mortality and hospitalisations among people with type 2 diabetes mellitus: A population-based study
- Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease
- Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
- Natural product pharmacology: the British Journal of Pharmacology perspective
- The double roles of T cell-mediated immune response in the progression of MASLD
- Editorial: Reciprocity between sleep and mood in early childhood - an under-explored neural marker of depression risk
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center
- Obituary: Travis Thompson-Editorial
- Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
- Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease
- Editorial: The Cass Review - implications and reassurance for practitioners
- Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis